Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketogenic Diet vs ACTH in West Syndrome
NCT05279118Phase 3Active, not recruiting
- Sponsor
- AIIMS New Delhi
- Start
- Apr 2022
- Primary completion
- Jul 2024
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial (2 arms), sponsored by AIIMS New Delhi. Primary endpoint: Mean percentage reduction of spasm at 6 weeks. Started Apr 2022; status: active, not recruiting.
Beyond the preview
Go deeper on NCT05279118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05279118.